Genetic mutations within tva receptor gene confer resistance to ALV-A and ALV-K infection in chickens Authors: Huijuan Xu, Huanqiang Chen, Meifeng Yang, Yongshen Wen, Zhixiang Kuang, Wanting Su, Sheng Chen, Qingmei Xie, Weiguo Chen Published: 2026 ABSTRACT Avian leukosis virus subgroup A (ALV-A) and the newly emerging subgroup K (ALV-K) are primary causative pathogens of avian leukosis in chickens and continue to pose a persistent threat to poultry industry worldwide. Susceptibility or resistance of chicken cells to ALV-A and ALV-K is determined by the tva receptor gene. Indeed, six ALV-A resistant alleles (tvar1-tvar6) have been identified within the tva gene. However, whether these tva alleles confer resistance to ALV-K infection remains unclear. In this study, we identified five tva resistant alleles, namely tvar2, tvar3, tvar4, tvar5, and tvar6, in Qingyuan partridge chickens (QYPC). In vitro analyses, including flow cytometry and quantitative real-time PCR, we demonstrated that the tvar2 allele confers complete resistance to both ALV-A and ALV-K infection. In contrast, the tvar3, tvar4, tvar5, and tvar6 alleles each significantly reduced susceptibility to ALV-K. Furthermore, these in vitro observations were corroborated by in vivo infection experiments, which confirmed that the tvar2 allele consistently conferred complete resistance to both ALV-A and ALV-K, while tvar3, tvar4, tvar5, and tvar6 alleles each resulted in a significant reduction in ALV-K susceptibility. Additionally, the tvar2-tvar6 alleles were broadly distributed across QYPC lines, with notably high frequencies of resistant genotypes observed in specific QYPC populations. Collectively, these findings not only expand our understanding of tva-mediated resistance to both ALV-A and ALV-K but also provide valuable genetic targets for selective breeding programs aimed at enhancing resistance to ALV-A and ALV-K in chickens. Introduction Avian leukosis viruses (ALVs) comprise a group of highly pathogenic avian retroviruses that induce a spectrum of neoplastic diseases, growth retardation, and profound immunosuppression in infected birds (Zhang et al., 2025; Fan et al., 2026). These viruses exhibit substantial genetic diversity, with chicken isolates phylogenetically categorized into seven distinct subgroups (designated A-E, J, and K) (Payne and Nair, 2012; Chen et al., 2025). ALVs are globally endemic in poultry populations, particularly in China and Southeast Asia, inflicting substantial economic losses on the poultry industry (Chen et al., 2022; Guo et al., 2023). To date, no effective commercial vaccines or antiviral therapeutics are available for the prevention and control of ALVs (Liu and Lan, 2026). Complete viral eradication remains elusive in China and Southeast Asia, rendering ALVs a persistent threat to domestic poultry production (Li et al., 2021; Zhang et al., 2024). Thus, exploring alternative control strategies is imperative, and selective breeding for ALV-resistant chickens has emerged as a promising approach (Bacon et al., 2000; Davies et al., 2009). ALV infection is primarily governed by the recognition of subgroup-specific cellular receptors (Smith et al., 2004; Li et al., 2022). Specifically, the Tva protein (encoded by the tva gene) serves as the receptor for ALV-A (Bates et al., 1993); Tvb (encoded by tvb) is the shared receptor for ALV-B, -D, and -E (Brojatsch. et al., 1996; Adkins. et al., 1997, 2001); Tvc (encoded by tvc) functions as the entry receptor for ALV-C (Elleder et al., 2005); and chicken sodium-hydrogen exchanger 1 (chNHE1, encoded by tvj) mediates ALV-J entry (Chai and Bates, 2006). Hence, these four receptor genes (tva, tvb, tvc, tvj) are critical determinants of chicken susceptibility or resistance to their respective ALV subgroups. Host resistance to ALV infection is primarily conferred by genetic defects in these receptor genes, which either abrogate receptor protein expression or encode non-functional receptor variants incapable of mediating viral entry (Kučerová et al., 2013; Li et al., 2018; Koslová et al., 2021). Among these, the tva receptor gene has been extensively characterized as a major genetic locus governing susceptibility or resistance to ALV-A (Young et al., 1993; Elleder et al., 2004). Indeed, six resistance alleles (tvar1 to tvar6) in the tva receptor gene have been identified in White Leghorn inbred lines and Chinese chicken breeds, each harboring distinct mutations that disrupt Tva function and confer heritable ALV-A resistance (Elleder et al., 2004; Reinišová et al., 2012; Chen et al., 2015). Specifically, the tvar1 allele harbors a missense mutation (g.631G>T), leading to a Cys40Trp substitution in Tva (Elleder et al., 2004); the tvar2 allele is defined by an insertion of "CTCG" (g.304_305insCTCG) in exon 1 (Elleder et al., 2004); and the tvar3 to tvar6 alleles are characterized by deletions within the first intron of the tva receptor gene, involving the sequences "ACCCCGCCCC", "ACCCC", "CGCTCACCCC", and "CGCTCACCCCGCCCC", respectively (Reinišová et al., 2012; Chen et al., 2015). These intronic deletions are hypothesized to impair the tva gene transcription or splicing, thereby reducing functional Tva expression. Subgroup K avian leukosis virus (ALV-K) is a newly identified subgroup isolated from Chinese Luhua chickens (Cui et al., 2014). Recent epidemiological investigations indicate its rapid spread among domestic chicken populations, rendering it a significant emerging threat to the global poultry industry, particularly in China and Southeast Asia (Li et al., 2024; Xu et al., 2025). ALV-K is known to utilize the Tva protein as its cellular receptor, the same as ALV-A (Přikryl et al., 2019). However, the role of these six identified tva alleles in ALV-K infection of domestic chickens remains unclear. Herein, we demonstrate that the tvar2 allele confers complete resistance to ALV-K, whereas the tvar3, tvar4, tvar5, and tvar6 alleles are responsible for reduced susceptibility to ALV-K infection in chickens. Materials and methods Ethics statement The experimental protocol involving animals was approved by the Animal Ethics Committee of South China Agricultural University (SCAU), Guangzhou, China (approval number: 2021b020). All animal procedures were conducted in accordance with the guidelines outlined in the Guidelines for the Care and Use of Laboratory Animals issued by the Animal Ethics Committee of SCAU. Experimental animals Our previous study identified the presence of the tvar2, tvar3, tvar4, tvar5, and tvar6 alleles in Qingyuan partridge chicken lines F, K, M, and W (Xu et al., 2025). These four QYPC lines were maintained by Guangdong Love-health Agriculture Group Ltd. (Guangdong, China). Cockerels and hens from these QYPC lines were obtained and maintained at the experimental animal center of South China Agricultural University (SCAU, Guangzhou, China). Chickens were housed separately by sex in individual cages under standard husbandry conditions. Fertilized eggs were incubated at 37.8°C and 60% relative humidity in an incubator with automatic 90° egg rotation every 2 h. Genotyping of tva alleles in Qingyuan partridge chicken Genomic DNA was extracted from blood samples of QYPC lines F, K, M, and W using a commercial DNA extraction kit (Tiangen Biotech, Beijing, China). The genomic region of the tva gene encompassing the tvar1, tvar2, tvar3, tvar4, tvar5, tvar6 alleles was polymerase chain reaction (PCR)-amplified using specific primer pairs as described previously (Xu et al., 2025). PCR products were subjected to bidirectional Sanger sequencing by Sangon Biotech Co., Ltd. (Guangzhou, China). The tva genotype of each sample was determined and confirmed based on sequence analysis. A total of 480 DNA samples from QYPC lines were genotyped for the six genetic resistant loci in the tva receptor gene. Cell culture and virus propagation Primary chicken embryo fibroblasts (CEFs) were isolated from 9 to 10-day-old embryos of QYPC lines K, F, W, and M as previously described (Li et al., 2018; Xu et al., 2025). The tva genotype of each CEF preparation was determined via Sanger sequencing as detailed above. CEFs and the DF-1 chicken fibroblast cell line were routinely cultured in Dulbecco’s Modified Eagle Medium (DMEM; Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS; Gibco), 100 U/mL penicillin, and 100 μg/mL streptomycin, and incubated at 39°C in a humidified atmosphere containing 5% CO₂. The infectious viruses RCASBP(A)-EGFP and RCASBP(K)-EGFP, which transduce the enhanced green fluorescent protein (EGFP) reporter gene, were generated by transfection of DF-1 cells with the RCASBP(A)-EGFP and RCASBP(K)-EGFP plasmid DNA. Viral supernatants were harvested at 7 days post-transfection, and cellular debris was cleared by centrifugation at 2,000 × g for 10 min at 4°C. Viral titers of RCASBP(A)-EGFP and RCASBP(K)-EGFP were quantified as previously described (Li et al., 2018). The ALV-A strain GD-08 and ALV-K strain GD-1601 were propagated in DF-1 cells. Viral titers were determined using a commercial avian leukosis virus (ALV) p27 antigen detection kit (Harbin Guosheng Biotechnology Co., Ltd., China) following the manufacturer’s instructions. Susceptibility assay of RCASBP(A)-EGFP and RCASBP(K)-EGFP using flow cytometry Susceptibility of QYPC lines to ALV-A and ALV-K were evaluated by RCASBP(A)-EGFP and RCASBP(K)-EGFP fluorescence reporter virus spread assay as previously described (Xu et al., 2025). Briefly, CEFs derived from genetically defined QYPC lines harboring either the tvar2 allele or the tvamut502-516 multiple allele (encompassing tvar3, tvar4, tvar5 and tvar6) (Chen et al., 2015) with distinct tva genotypes were seeded in triplicate (at a density of 5×10⁵ cells/well) in 12-well plates. Following 24 h of incubation, the tvas/s, tvas/r2, tvar2/r2 CEFs were infected with RCASBP(A)-EGFP or RCASBP(K)-EGFP, while CEFs with defined genotypes from the tvamut502-516 multiple allele were infected with RCASBP(K)-EGFP, at a multiplicity of infection (MOI) of 10, or maintained as uninfected controls. After a 2-hour viral adsorption period, cultures were incubated in DMEM supplemented with 1% FBS under standard incubation conditions (39°C, 5% CO₂) for 7 days. The kinetics of GFP expression were quantified at 1, 2, 3, and 7 days post-infection (dpi) using a BD FACS Calibur flow cytometer (BD Biosciences, USA). Prior to analysis, triplicate wells were trypsinized, washed with phosphate-buffered saline (PBS), and subjected to flow cytometric analysis to determine GFP fluorescence intensity. Data are presented as the percentage of GFP-positive cells relative to the total cell population. Susceptibility assay of ALV-A and ALV-K via real-time quantitative PCR (RT-qPCR) To further assess ALV-A and ALV-K susceptibility, CEFs derived from genetically characterized QYPC lines were employed, including those harboring either the tvar2 allele or the tvamut502-516 multiple allele (encompassing tvar3, tvar4, tvar5 and tvar6) with distinct tva genotypes. CEFs were seeded in triplicate wells of 12-well plates at a density of 5 × 10⁵ cells/well. At 24 h post-seeding, the tvas/s, tvas/r2, tvar2/r2 CEFs were infected with ALV-A strain GD-08 (S/P ratio = 2.2) or ALV-K strain GD-1601(S/P ratio = 2.1), while CEFs with defined genotypes from the tvamut502-516 multiple allele were infected with ALV-K strain GD-1601, at a MOI of 1. After a 2-h viral adsorption period, the inoculum was replaced with fresh DMEM, and cells were incubated at 37°C in a 5% CO2 atmosphere for 4 days. Infected cell cultures were harvested at 1, 2, 3, and 4 days post-infection (dpi) for subsequent RNA extraction and cDNA synthesis. Viral progeny titers were quantified as viral RNA copies per mL using RT-qPCR with ALV-K-specific primer pairs, as previously described (Xu et al., 2025). The GAPDH gene served as an internal control for normalization. Data are presented as the mean ± standard error of the mean (SEM) derived from three independent experiments. Infection experiment by ALV-A and ALV-K in vivo To evaluate ALV-A and ALV-K susceptibility in vivo, two independent animal experiments were conducted using 1-day-old QYPC chicks. In the first experiment, chicks randomly selected from QYPC lines harboring the tvar2 allele with different genotypes were randomly allocated into two groups (n = 30 chicks per group). In the other separate independent animal experiment, chicks randomly selected from QYPC lines carrying the tvamut502-516 multiple allele (encompassing tvar3, tvar4, tvar5 and tvar6) with distinct tva genotypes were randomly divided into four groups (n = 30 chicks per group). For each experimental group, 3 age-matched specific pathogen-free (SPF) chicks served as negative controls in each group. All chicks were housed in negative-pressure air isolators, with ad libitum access to commercial feed and sterile water. Chicks with defined genotypes from the tvar2 allele were inoculated intraperitoneally with 0.5 mL of ALV-A strain GD-08 and ALV-K strain GD-1601, respectively; chicks with defined genotypes from the tvamut502-516 multiple allele were inoculated intraperitoneally with 0.5 mL of ALV-K strain GD-1601 at 1 day old, followed by a booster inoculation at 5 days old. At 2 weeks of age, whole blood samples were collected from each chick for genomic DNA extraction, and genotypes of the tva alleles were confirmed via direct Sanger sequencing. At 1 month post-inoculation, ALV-A and ALV-K infection status in each chick was determined using a previously established protocol (Xu et al., 2025). Statistical analysis Statistical analyses were conducted using GraphPad Prism software (version 8.0; GraphPad Software Inc., La Jolla, CA, USA). In vitro infection experiments were performed with at least three independent biological replicates, and results are presented as the mean ± standard deviation (SD). Results Identification of the tva Alleles in Qingyuan partridge chicken lines To investigate the presence and distribution of tva alleles in Qingyuan Partridge Chicken (QYPC) lines F, K, M, and W, genomic regions encompassing the previously reported six tva alleles (tvar1, tvar2, tvar3, tvar4, tvar5, tvar6) were amplified and sequenced for each bird. Sequence analysis revealed the presence of the tvar2 allele, which is characterized by a CTCG insertion (g.304_305insCTCG) within exon 1 of the tva gene, in the surveyed QYPC population (Fig. 1A). Representative sequence traces corresponding to the wild-type (tvas/s), heterozygous (tvas/r2), and homozygous (tvar2/r2) genotypes for the tvar2 allele are illustrated in Fig. 1B. Additionally, sequence analysis identified the presence of tvar3, tvar4, tvar5 and tvar6 alleles, which have been previously designated as part of the tvamut502-516 multiple allele series (Chen et al., 2015). These alleles are characterized by distinct deletions within the first intron of the tva receptor gene: "ACCCCGCCCC" for tvar3, "ACCCC" for tvar4, "CGCTCACCCC" for tvar5, and "CGCTCACCCCGCCCC" for tvar6 (Fig. 1A). All genotypes associated with the tvamut502-516 multiple allele were identified in the surveyed QYPC population, with their representative sequence traces depicted in Fig. 1C. This included the wild-type (tvas/s), homozygous genotypes (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6), and two categories of heterozygous genotypes. The first category included heterozygotes between the wild-type and each mutant allele (tvas/r3, tvas/r4, tvas/r5, tvas/r6), whereas the second category consisted of heterozygotes between different mutant alleles (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6). Collectively, these results confirm the presence of the tvar2, tvar3, tvar4, tvar5, and tvar6 resistant alleles within the QYPC lines.Fig. 1Identification of ALV resistance-associated tva alleles in Qingyuan Partridge chickens. (A) Schematic representation of the tva receptor gene structure. The tvar2 allele and tvamut502-516 multiple alleles (tvar3, tvar4, tvar5, tvar6) are localized within exon 1 and intron 1 of the tva gene, respectively. (B) Representative Sanger sequencing chromatograms of the tvar2 allele, showing wild-type (tvas/s), heterozygous (tvas/r2), and homozygous (tvar2/r2) genotypes. The 4-nucleotide (CTCG) insertion characteristic of thetvar2 allele is highlighted with a red line. (C) Representative Sanger sequencing chromatograms of the tvamut502-516, including wild-type (tvas/s), homozygous genotypes (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6), and heterozygous genotypes (tvas/r3, tvas/r4, tvas/r5, tvas/r6 and tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6). The specific deletion sequences for each allele are highlighted with red lines: tvar3 (ACCCCGCCCC), tvar4 (ACCCC), tvar5 (CGCTCACCCC), and tvar6 (CGCTCACCCCGCCCC). Identification of ALV resistance-associated tva alleles in Qingyuan Partridge chickens. (A) Schematic representation of the tva receptor gene structure. The tvar2 allele and tvamut502-516 multiple alleles (tvar3, tvar4, tvar5, tvar6) are localized within exon 1 and intron 1 of the tva gene, respectively. (B) Representative Sanger sequencing chromatograms of the tvar2 allele, showing wild-type (tvas/s), heterozygous (tvas/r2), and homozygous (tvar2/r2) genotypes. The 4-nucleotide (CTCG) insertion characteristic of thetvar2 allele is highlighted with a red line. (C) Representative Sanger sequencing chromatograms of the tvamut502-516, including wild-type (tvas/s), homozygous genotypes (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6), and heterozygous genotypes (tvas/r3, tvas/r4, tvas/r5, tvas/r6 and tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6). The specific deletion sequences for each allele are highlighted with red lines: tvar3 (ACCCCGCCCC), tvar4 (ACCCC), tvar5 (CGCTCACCCC), and tvar6 (CGCTCACCCCGCCCC). The tvar2 allele confer Qingyuan partridge chicken complete resistance to ALV-A and ALV-K infection in vitro The tvar2 allele, characterized by a CTCG insertion, has been hypothesized to preclude the expression of functional Tva proteins (Elleder et al., 2004). However, direct experimental evidence confirming that the tvar2 allele confers resistance to ALV-A and ALV-K infection in chickens has remained elusive. To rigorously assess the impact of the tvar2 allele on host susceptibility to ALV-A and ALV-K, the tvas/s, tvas/r2, tvar2/r2 CEFs were inoculated with the replication-competent retroviral vectors RCASBP(A)-EGFP or RCASBP(K)-EGFP, which express EGFP as a reporter. The percentage of EGFP-positive cells was quantified by flow cytometry (FACS) over a 7-day period. The wild-type tvas/s CEFs, known to be susceptible to ALV-A and ALV-K, served as positive controls. As anticipated, both RCASBP(A)-EGFP and RCASBP(K)-EGFP efficiently infected tvas/s CEFs, achieving approximately 60% GFP-positive cells as early as day 1 post-inoculation, with near-complete infection by day 7 (Fig. 2A and 2B). In stark contrast, RCASBP(A)-EGFP and RCASBP(K)-EGFP failed to productively infect tvar2/r2 CEFs, as minimal to no GFP-positive cells were detected throughout the 7-day observation period (Fig. 2, Fig. 2). Conversely, tvas/r2 CEFs displayed a high degree of susceptibility to both RCASBP(A)-EGFP and RCASBP(K)-EGFP, with GFP-positive cells reaching 83.2% and 80.1% by day 7, respectively (Fig. 2, Fig. 2). The clear distinction between GFP-negative and GFP-positive cell populations was further confirmed by representative FACS dot plots (Fig. 2, Fig. 2). These results strongly indicate that tvar2/r2 CEFs are completely resistant to infection by RCASBP(K)-EGFP, and by extension, RCASBP(A)-EGFP.Fig. 2The time course of ALV-A and ALV-K infection in CEFs with distinct tvar2 genotypes. (A and B) The tvas/s, tvas/r2 and tvar2/r2 CEFs were infected with RCASBP(A)-EGFP or RCASBP(K)-EGFP at a multiplicity of infection (MOI) of 10. The percentage of GFP-positive cells was quantified by flow cytometry (FACS) at indicated time points post-infection (dpi). Data are presented as mean ± standard deviation (SD) from three replicate cultures. (C and D) Representative FACS dot plots of mock-infected control CEFs and tvas/s, tvas/r2 and tvar2/r2 CEFs infected with RCASBP(A)-EGFP or RCASBP(K)-EGFP at 7 dpi. Relative GFP fluorescence intensity is plotted against cell count, with the percentage of GFP-positive cells (within the gated region) indicated. (E and F)tvas/s, tvas/r2 and tvar2/r2 CEFs were infected with ALV-A strain GD-08 (E) or ALV-K strain GD-1601 (F) at MOI of 0.1. Cell culture supernatant-associated viruses were harvested at 1, 2, 3, and 4 dpi, and viral titers were quantified as viral RNA copies via reverse transcription-quantitative PCR (RT-qPCR). Growth curves represent mean ± SD from three independent experiments, each performed in triplicate. The time course of ALV-A and ALV-K infection in CEFs with distinct tvar2 genotypes. (A and B) The tvas/s, tvas/r2 and tvar2/r2 CEFs were infected with RCASBP(A)-EGFP or RCASBP(K)-EGFP at a multiplicity of infection (MOI) of 10. The percentage of GFP-positive cells was quantified by flow cytometry (FACS) at indicated time points post-infection (dpi). Data are presented as mean ± standard deviation (SD) from three replicate cultures. (C and D) Representative FACS dot plots of mock-infected control CEFs and tvas/s, tvas/r2 and tvar2/r2 CEFs infected with RCASBP(A)-EGFP or RCASBP(K)-EGFP at 7 dpi. Relative GFP fluorescence intensity is plotted against cell count, with the percentage of GFP-positive cells (within the gated region) indicated. (E and F)tvas/s, tvas/r2 and tvar2/r2 CEFs were infected with ALV-A strain GD-08 (E) or ALV-K strain GD-1601 (F) at MOI of 0.1. Cell culture supernatant-associated viruses were harvested at 1, 2, 3, and 4 dpi, and viral titers were quantified as viral RNA copies via reverse transcription-quantitative PCR (RT-qPCR). Growth curves represent mean ± SD from three independent experiments, each performed in triplicate. To further validate these observations and to extend the findings to authentic ALV isolates, tvas/s, tvas/r2, tvar2/r2 CEFs were infected with the ALV-A strain GD-08 and the ALV-K strain GD-1601. Viral growth kinetics were subsequently determined by RT-qPCR. As illustrated in Fig. 2, Fig. 2, both ALV-A GD-08 and ALV-K GD-1601 replicated robustly in tvas/s CEFs, achieving viral titers exceeding 108 copies/mL by 4 days post-infection (dpi). In marked contrast, no appreciable viral replication was detected for either ALV-A GD-08 or ALV-K GD-1601 in tvar2/r2 CEFs (Fig. 2, Fig. 2). The tvas/r2 CEFs were efficiently infected by both ALV-A GD-08 and ALV-K GD-1601, exhibiting growth kinetics comparable to those observed in tvas/s CEFs (Fig. 2, Fig. 2). Taken together, these data offer compelling evidence that the tvar2 allele confers complete resistance to ALV-A and ALV-K infections in host cells in vitro. The tvar3, tvar4, tvar5, tvar6 alleles each reduce the susceptibility to ALV-K infection in vitro To investigate the impact of the tvamut502-516 multiple allele (tvar3, tvar4, tvar5, tvar6) on susceptibility to ALV-K, CEFs with defined genotypes were infected with the fluorescent reporter virus RCASBP(K)-EGFP, and viral infection efficiency was dynamically monitored. As anticipated, wild-type tvas/s CEFs exhibited high susceptibility to RCASBP(K)-EGFP. Specifically, the infection rate exceeded 60% at 1 day post-infection (dpi), and nearly all cells were infected by 3 dpi (Fig. 3A and 3B). In striking contrast, CEFs homozygous for the tvamut502-516 allele (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6) showed markedly reduced susceptibility. At 1 dpi, only 1%-2% of cells were infected, and viral spread remained limited, with infection rates reaching only 24.2%, 21.1%, 20.7%, and 22.8% by 7 dpi for tvar3/r3, tvar4/r4, tvar5/r5, and tvar6/r6 CEFs, respectively (Fig. 3C). Two categories of heterozygous CEFs were also further evaluated for ALV-K susceptibility. CEFs heterozygous for the wild-type tva and tvamut502-516 allele (tvas/r3, tvas/r4, tvas/r5, tvas/r6) retained high susceptibility to RCASBP(K)-EGFP, with infection rates ranging from 87.8% to 91.2% at 7 dpi (Fig. 3, Fig. 3). Conversely, CEFs heterozygous for two distinct tvamut502-516 allele (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6) exhibited inefficient infection, with rates ranging from 17.2% to 22.7% by 7 dpi (Fig. 3, Fig. 4). These findings collectively indicate that both homozygous (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6) and inter-allelic heterozygous (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6) CEFs carrying tvamut502-516 allele exhibit significantly reduced susceptibility to ALV-K infection.Fig. 3Time course of RCASBP(K)-EGFP infection in CEFs with distinct genotypes for tvamut502-516 multiple allele. CEFs with defined tvamut502-516 genotypes were infected with the RCASBP(K)-EGFP reporter viruses at a multiplicity of infection (MOI) of 10.(A) The percentage of GFP-positive cells was quantified by flow cytometry (FACS) at indicated days post-infection (dpi) for CEFs of the wild-type tvas/s, homozygous genotypes (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6), and heterozygous genotypes (tvas/r3, tvas/r4, tvas/r5, tvas/r6). Data are presented as mean ± standard deviation (SD) from three replicate cultures. (B) FACS analysis of GFP-positive cell proportions at indicated dpi for wild-type tvas/s CEFs and CEFs with inter-allelic heterozygous genotypes of tvamut502-516 (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6). (C) Representative FACS dot plots of mock-infected control CEFs and tvamut502-516 genotyped CEFs infected with RCASBP(K)-EGFP at 7 dpi. Relative GFP fluorescence intensity is plotted against cell count, with the percentage of GFP-positive cells (within the gated region) indicated.Fig. 4Replication kinetics of ALV-K wild-type strain GD1601 in CEFs with distinct tvamut502-516 genotypes. CEFs harboring distinct tvamut502-516 genotypes were infected with ALV-K wild-type strain GD1601 at a multiplicity of infection (MOI) of 0.1. Cell culture supernatant-associated viruses were harvested at 1, 2, 3, and 4 days post-infection (dpi), and viral titers were quantified as viral RNA copies via reverse transcription-quantitative PCR (RT-qPCR). Data are presented as mean ± standard deviation (SD) from three independent experiments, each performed in triplicate. (A) Replication kinetics of ALV-K in wild-type tvas/s CEFs, homozygous tvamut502-516 CEFs (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6), and heterozygous CEFs carrying wild-type and mutant alleles (tvas/r3, tvas/r4, tvas/r5, tvas/r6). (B) Replication kinetics of ALV-K in wild-type tvas/s CEFs and inter-allelic heterozygous CEFs of tvamut502-516 (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6). Time course of RCASBP(K)-EGFP infection in CEFs with distinct genotypes for tvamut502-516 multiple allele. CEFs with defined tvamut502-516 genotypes were infected with the RCASBP(K)-EGFP reporter viruses at a multiplicity of infection (MOI) of 10. (A) The percentage of GFP-positive cells was quantified by flow cytometry (FACS) at indicated days post-infection (dpi) for CEFs of the wild-type tvas/s, homozygous genotypes (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6), and heterozygous genotypes (tvas/r3, tvas/r4, tvas/r5, tvas/r6). Data are presented as mean ± standard deviation (SD) from three replicate cultures. (B) FACS analysis of GFP-positive cell proportions at indicated dpi for wild-type tvas/s CEFs and CEFs with inter-allelic heterozygous genotypes of tvamut502-516 (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6). (C) Representative FACS dot plots of mock-infected control CEFs and tvamut502-516 genotyped CEFs infected with RCASBP(K)-EGFP at 7 dpi. Relative GFP fluorescence intensity is plotted against cell count, with the percentage of GFP-positive cells (within the gated region) indicated. Replication kinetics of ALV-K wild-type strain GD1601 in CEFs with distinct tvamut502-516 genotypes. CEFs harboring distinct tvamut502-516 genotypes were infected with ALV-K wild-type strain GD1601 at a multiplicity of infection (MOI) of 0.1. Cell culture supernatant-associated viruses were harvested at 1, 2, 3, and 4 days post-infection (dpi), and viral titers were quantified as viral RNA copies via reverse transcription-quantitative PCR (RT-qPCR). Data are presented as mean ± standard deviation (SD) from three independent experiments, each performed in triplicate. (A) Replication kinetics of ALV-K in wild-type tvas/s CEFs, homozygous tvamut502-516 CEFs (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6), and heterozygous CEFs carrying wild-type and mutant alleles (tvas/r3, tvas/r4, tvas/r5, tvas/r6). (B) Replication kinetics of ALV-K in wild-type tvas/s CEFs and inter-allelic heterozygous CEFs of tvamut502-516 (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6). To validate these observations and quantify viral replication kinetics, genetically defined CEFs from the tvamut502-516 multiple allele were infected with the ALV-K strain GD-1601, and viral loads were monitored by RT-qPCR over a 4-day period. As shown in Fig. 4, Fig. 4, ALV-K GD-1601 replicated robustly in wild-type tvas/s CEFs, reaching a titer of ∼10⁸ virus copies/mL by 4 dpi. In contrast, viral replication was severely restricted in tvamut502-516 homozygous CEFs (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6) and inter-allelic heterozygous CEFs (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6), with both groups yielding only ∼102 virus copies/mL by 4 dpi (Fig. 4, Fig. 4). Notably, CEFs heterozygous for the wild-type tva and a tvamut502-516 allele (tvas/r3, tvas/r4, tvas/r5, tvas/r6) supported efficient ALV-K replication, with growth kinetics mirroring those of wild-type tvas/s CEFs (Fig. 4A). Collectively, these results formally demonstrate that the tvar3, tvar4, tvar5, and tvar6 alleles confer reduced susceptibility to ALV-K infection in vitro. The tva alleles determine Qingyuan partridge chicken resistance to ALV-A and ALV-K infection in vivo To validate the in vitro observations in an in vivo context, we performed experimental challenge studies using randomly selected chicks derived from QYPC lines, inoculated with either ALV-A or ALV-K. 1-day-old chicks were intraperitoneally inoculated with ALV-A strain GD-08 or ALV-K strain GD-1601, followed by a booster inoculation at 5 days of age. At 1 month post-infection, the infection status of ALV-A or ALV-K in each chick was assessed via reverse transcription-polymerase chain reaction (RT-PCR) using total RNA extracted from whole blood samples. All SPF chicks inoculated with ALV-A GD-08 or ALV-K GD-1601 tested positive for the respective virus by RT-PCR, confirming the efficacy of the challenge protocol. As expected, all 12 wild-type (tvas/s) chicks and 15 wild-type (tvas/s) chicks were positive for ALV-A and ALV-K, respectively (Table 1, Table 2). Among 15 tvas/r2 heterozygous chicks, 13 tested positive for ALV-A (Table 1), similarly, 11 of 14 tvas/r2 heterozygotes were ALV-K-positive (Table 2). In contrast, tvar2/r2 homozygous chicks were completely negative for both ALV-A and ALV-K (Table 1, Table 2).Table 1Incidence of subgroup A ALV infection in different genotypes of the tvar2 allele.ChicksGenotypes2No. of positive samples/total no. of samplesPositive infection (%)SPFtvas/s6/6100QYPC1 chickstvas/s12/12100tvas/r213/1586.6tvar2/r20/1301QYPC= Qingyuan partridge chicken2tvas/s = susceptible homozygote of tva receptor gene (wild genotype); tvas/r2=heterozygote of insert CTCG; tvar2/r2= homozygote of insert CTCG.Table 2Incidence of subgroup K ALV infection in different genotypes of the tvar2 allele.ChicksGenotypes2No. of positive samples/total no. of samplesPositive infection (%)SPFtvas/s6/6100QYPC1 chickstvas/s15/15100tvas/r211/1478.6tvar2/r20/1101QYPC= Qingyuan partridge chicken2tvas/s = susceptible homozygote of tva receptor gene (wild genotype); tvas/r2=heterozygote of insert CTCG; tvar2/r2= homozygote of insert CTCG. Table 1Incidence of subgroup A ALV infection in different genotypes of the tvar2 allele.ChicksGenotypes2No. of positive samples/total no. of samplesPositive infection (%)SPFtvas/s6/6100QYPC1 chickstvas/s12/12100tvas/r213/1586.6tvar2/r20/1301QYPC= Qingyuan partridge chicken2tvas/s = susceptible homozygote of tva receptor gene (wild genotype); tvas/r2=heterozygote of insert CTCG; tvar2/r2= homozygote of insert CTCG. Incidence of subgroup A ALV infection in different genotypes of the tvar2 allele. QYPC= Qingyuan partridge chicken tvas/s = susceptible homozygote of tva receptor gene (wild genotype); tvas/r2=heterozygote of insert CTCG; tvar2/r2= homozygote of insert CTCG. Table 2Incidence of subgroup K ALV infection in different genotypes of the tvar2 allele.ChicksGenotypes2No. of positive samples/total no. of samplesPositive infection (%)SPFtvas/s6/6100QYPC1 chickstvas/s15/15100tvas/r211/1478.6tvar2/r20/1101QYPC= Qingyuan partridge chicken2tvas/s = susceptible homozygote of tva receptor gene (wild genotype); tvas/r2=heterozygote of insert CTCG; tvar2/r2= homozygote of insert CTCG. Incidence of subgroup K ALV infection in different genotypes of the tvar2 allele. QYPC= Qingyuan partridge chicken tvas/s = susceptible homozygote of tva receptor gene (wild genotype); tvas/r2=heterozygote of insert CTCG; tvar2/r2= homozygote of insert CTCG. An independent ALV-K challenge experiment was conducted to further validate the role of deletion polymorphisms of the tvamut502-516 multiple allele in viral susceptibility. As expected, all SPF chicks (positive controls) and the wild-type (tvas/s) chicks were positive for ALV-K. In contrast, tvas/r3, tvas/r4, tvas/r5 and tvas/r6 heterozygous chicks maintained high susceptibility to ALV-K infection. Specifically, among cohorts of 6, 6, 5, and 4 chicks for tvas/r3, tvas/r4, tvas/r5 and tvas/r6, respectively, all were ALV-K-positive except for one tvas/r3 chick (Table 3). Conversely, ALV-K susceptibility was significantly reduced in homozygous mutant chicks (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6) and heterozygous mutant chicks (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6). Detailed analysis revealed minimal viral detection in these groups: of the homozygous mutant cohorts (tvar3/r3: n = 13; tvar4/r4: n = 9; tvar5/r5: n = 12; tvar6/r6: n = 6) and compound heterozygous mutant cohorts (tvar3/r4: n = 11; tvar3/r5: n = 8; tvar3/r6: n = 5; tvar4/r5: n = 9; tvar4/r6: n = 6; tvar5/r6: n = 5), only 1 tvar3/r3, 2 tvar5/r5, and 1 tvar3/r5 chick tested positive for ALV-K (Table 3). These findings indicate that in vivo infection outcomes are consistent with the in vitro viral entry data, confirming complete resistance of tvar2/r2 homozygotes to both ALV-A and ALV-K, and reduced ALV-K susceptibility in homozygous (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6) and heterozygous (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6) mutant chicks.Table 3Incidence of subgroup K ALV infection in different genotypes of the tvamut502–516 multiple allele.ChicksGenotypes2No. of positive samples/total no. of samplesPositive infection (%)SPFtvas/s12/12100QYPC1 chickstvas/s17/17100tvas/r35/683.3tvas/r46/6100tvas/r55/5100tvas/r64/4100tvar3/r31/119.1tvar4/r40/90tvar5/r52/1216.7tvar6/r60/60tvar3/r40/110tvar3/r51/812.5tvar3/r60/50tvar4/r50/90tvar4/r60/60tvar5/r60/501QYPC= Qingyuan partridge chicken2tvas/s=susceptible homozygote of tva receptor gene (wild genotype); tvas/r3=heterozygote of deleted ACCCCGCCCC; tvas/r4=heterozygote of deleted ACCCC; tvas/r5=heterozygote of deleted CGCTCACCCC; tvas/r6=heterozygote of deleted CGCTCACCCCGCCCC; tvar3/r3=homozygote of deleted ACCCCGCCCC; tvar4/r4=homozygote of deleted ACCCC; tvar5/r5=homozygote of deleted CGCTCACCCC; tvar6/r6=homozygote of deleted CGCTCACCCCGCCCC; tvar3/r4=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r5=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r6=heterozygote of deleted ACCCCGCCCC and CGCTCACCCCGCCCC; tvar4/r5=heterozygote of deleted ACCCC and CGCTCACCCC; tvar4/r6= heterozygote of deleted ACCCC and CGCTCACCCCGCCCC; tvar5/r6= heterozygote of deleted CGCTCACCCC and CGCTCACCCCGCCCC. Table 3Incidence of subgroup K ALV infection in different genotypes of the tvamut502–516 multiple allele.ChicksGenotypes2No. of positive samples/total no. of samplesPositive infection (%)SPFtvas/s12/12100QYPC1 chickstvas/s17/17100tvas/r35/683.3tvas/r46/6100tvas/r55/5100tvas/r64/4100tvar3/r31/119.1tvar4/r40/90tvar5/r52/1216.7tvar6/r60/60tvar3/r40/110tvar3/r51/812.5tvar3/r60/50tvar4/r50/90tvar4/r60/60tvar5/r60/501QYPC= Qingyuan partridge chicken2tvas/s=susceptible homozygote of tva receptor gene (wild genotype); tvas/r3=heterozygote of deleted ACCCCGCCCC; tvas/r4=heterozygote of deleted ACCCC; tvas/r5=heterozygote of deleted CGCTCACCCC; tvas/r6=heterozygote of deleted CGCTCACCCCGCCCC; tvar3/r3=homozygote of deleted ACCCCGCCCC; tvar4/r4=homozygote of deleted ACCCC; tvar5/r5=homozygote of deleted CGCTCACCCC; tvar6/r6=homozygote of deleted CGCTCACCCCGCCCC; tvar3/r4=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r5=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r6=heterozygote of deleted ACCCCGCCCC and CGCTCACCCCGCCCC; tvar4/r5=heterozygote of deleted ACCCC and CGCTCACCCC; tvar4/r6= heterozygote of deleted ACCCC and CGCTCACCCCGCCCC; tvar5/r6= heterozygote of deleted CGCTCACCCC and CGCTCACCCCGCCCC. Incidence of subgroup K ALV infection in different genotypes of the tvamut502–516 multiple allele. QYPC= Qingyuan partridge chicken tvas/s=susceptible homozygote of tva receptor gene (wild genotype); tvas/r3=heterozygote of deleted ACCCCGCCCC; tvas/r4=heterozygote of deleted ACCCC; tvas/r5=heterozygote of deleted CGCTCACCCC; tvas/r6=heterozygote of deleted CGCTCACCCCGCCCC; tvar3/r3=homozygote of deleted ACCCCGCCCC; tvar4/r4=homozygote of deleted ACCCC; tvar5/r5=homozygote of deleted CGCTCACCCC; tvar6/r6=homozygote of deleted CGCTCACCCCGCCCC; tvar3/r4=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r5=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r6=heterozygote of deleted ACCCCGCCCC and CGCTCACCCCGCCCC; tvar4/r5=heterozygote of deleted ACCCC and CGCTCACCCC; tvar4/r6= heterozygote of deleted ACCCC and CGCTCACCCCGCCCC; tvar5/r6= heterozygote of deleted CGCTCACCCC and CGCTCACCCCGCCCC. Polymorphisms of the tva resistant loci in the Qingyuan partridge chicken To investigate the distribution of tva resistance alleles in Qingyuan Partridge Chicken (QYPC) lines F, K, M, and W, we amplified and sequenced the tva genomic region encompassing tvar2, tvar3, tvar4, tvar5 and tvar6 resistance alleles. Sequencing results revealed distinct differences in the allelic and genotypic frequencies of these resistance alleles among QYPC lines (Table 4, Table 5). The tvar2 allele was detected in QYPC lines F, K, and M, with allelic frequencies of 0.05, 0.08, and 0.09, respectively. Correspondingly, the homozygous resistant genotype tvar2/r2 was identified in these lines, with frequencies of 0.03, 0.05, and 0.05, respectively. Additionally, a total of 15 genotypes were observed for the tvamut502-516 multiple allele across all tested chickens. The average allelic frequencies of tvas (wild-type), tvar3, tvar4, tvar5 and tvar6 in QYPC lines were 0.29, 0.25, 0.22, 0.18, and 0.06, respectively, with ranges of 0.20-0.40, 0.22-0.29, 0.09-0.33, 0.12-0.22, and 0-0.15. The wild-type susceptible genotype tvas/s was present in all QYPC lines, with an average frequency of 0.24. Heterozygous susceptible genotypes (tvas/r3, tvas/r4, tvas/r5 and tvas/r6) were detected in most lines, with average frequencies of 0.03, 0.03, 0.02, and 0.01, respectively. In contrast, homozygous resistant genotypes (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6) and heterozygous resistant genotypes (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6) were identified in the tested QYPC population, with average frequencies of 0.15, 0.12, 0.10, 0.03 and 0.10, 0.06, 0.02, 0.05, 0.01, 0.02, respectively. These findings indicate that both the tvar2 allele and the tvamut502-516 multiple-allele locus hold potential as genetic markers for improving resistance to ALV-A and ALV-K in QYPC through selective breeding.Table 4Allelic frequency of resistance alleles within the tva receptor gene in QYPC1 lines.LinesNo.tvar2 allele2tvamut502–516 multiple allele3tvastvar2tvastvar3tvar4tvar5tvar6F1200.950.050.240.220.330.220K1200.920.080.310.280.090.180.15M1200.910.090.400.230.250.120W120100.200.290.220.190.10Average4800.940.060.290.250.220.180.061QYPC= Qingyuan partridge chicken2The tvar2 allele harbors an insertion of "CTCG" within exon 1 in the tva receptor gene.3The tvamut502–516 is multiple allele of tvar3, tvar4, tvar5 and tvar6 in the tva receptor gene. The tvar3, tvar4, tvar5 and tvar6 alleles are characterized by deletions within the first intron of the tva receptor gene, involving the sequences "ACCCCGCCCC", "ACCCC", "CGCTCACCCC", and "CGCTCACCCCGCCCC", respectively.Table 5Genotypic frequency of resistant alleles within the tva receptor gene in Qingyuan Partridge Chicken lines.LinesNo.tvar2 allele1tvamut502–516 multiple allele2tvas/stvas/r2tvar2/r2tvas/stvas/r3tvas/r4tvas/r5tvas/r6tvar3/r3tvar4/r4tvar5/r5tvar6/r6tvar3/r4tvar3/r5tvar3/r6tvar4/r5tvar4/r6tvar5/r6F1200.920.060.030.2100.030.0300.110.180.1400.180.0400.0800K1200.880.070.050.260.0300.040.030.150.040.080.060.060.110.0500.030.06M1200.880.080.050.330.060.050.0300.140.160.0600.080.0400.0600W1201000.150.030.0500.020.180.120.130.050.080.060.040.040.030.03Average4800.920.050.030.240.030.030.020.010.150.120.100.030.100.060.020.050.010.021The tvar2 allele harbors an insertion of "CTCG" within exon 1 in the tva receptor gene. tvas/s=susceptible homozygote of tva receptor gene (wild genotype); tvas/r2=heterozygote of inserted CTCG; tvar2/r2=homozygote of inserted CTCG.2The tvamut502–516 is multiple allele of tvar3, tvar4, tvar5 and tvar6 in the tva receptor gene. tvas/s=susceptible homozygote of tva receptor gene (wild genotype); tvas/r3=heterozygote of deleted ACCCCGCCCC; tvas/r4=heterozygote of deleted ACCCC; tvas/r5=heterozygote of deleted CGCTCACCCC; tvas/r6=heterozygote of deleted CGCTCACCCCGCCCC; tvar3/r3=homozygote of deleted ACCCCGCCCC; tvar4/r4=homozygote of deleted ACCCC; tvar5/r5=homozygote of deleted CGCTCACCCC; tvar6/r6=homozygote of deleted CGCTCACCCCGCCCC; tvar3/r4=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r5=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r6=heterozygote of deleted ACCCCGCCCC and CGCTCACCCCGCCCC; tvar4/r5=heterozygote of deleted ACCCC and CGCTCACCCC; tvar4/r6= heterozygote of deleted ACCCC and CGCTCACCCCGCCCC; tvar5/r6= heterozygote of deleted CGCTCACCCC and CGCTCACCCCGCCCC. Table 4Allelic frequency of resistance alleles within the tva receptor gene in QYPC1 lines.LinesNo.tvar2 allele2tvamut502–516 multiple allele3tvastvar2tvastvar3tvar4tvar5tvar6F1200.950.050.240.220.330.220K1200.920.080.310.280.090.180.15M1200.910.090.400.230.250.120W120100.200.290.220.190.10Average4800.940.060.290.250.220.180.061QYPC= Qingyuan partridge chicken2The tvar2 allele harbors an insertion of "CTCG" within exon 1 in the tva receptor gene.3The tvamut502–516 is multiple allele of tvar3, tvar4, tvar5 and tvar6 in the tva receptor gene. The tvar3, tvar4, tvar5 and tvar6 alleles are characterized by deletions within the first intron of the tva receptor gene, involving the sequences "ACCCCGCCCC", "ACCCC", "CGCTCACCCC", and "CGCTCACCCCGCCCC", respectively. Allelic frequency of resistance alleles within the tva receptor gene in QYPC1 lines. 1QYPC= Qingyuan partridge chicken 2The tvar2 allele harbors an insertion of "CTCG" within exon 1 in the tva receptor gene. 3The tvamut502–516 is multiple allele of tvar3, tvar4, tvar5 and tvar6 in the tva receptor gene. The tvar3, tvar4, tvar5 and tvar6 alleles are characterized by deletions within the first intron of the tva receptor gene, involving the sequences "ACCCCGCCCC", "ACCCC", "CGCTCACCCC", and "CGCTCACCCCGCCCC", respectively. Table 5Genotypic frequency of resistant alleles within the tva receptor gene in Qingyuan Partridge Chicken lines.LinesNo.tvar2 allele1tvamut502–516 multiple allele2tvas/stvas/r2tvar2/r2tvas/stvas/r3tvas/r4tvas/r5tvas/r6tvar3/r3tvar4/r4tvar5/r5tvar6/r6tvar3/r4tvar3/r5tvar3/r6tvar4/r5tvar4/r6tvar5/r6F1200.920.060.030.2100.030.0300.110.180.1400.180.0400.0800K1200.880.070.050.260.0300.040.030.150.040.080.060.060.110.0500.030.06M1200.880.080.050.330.060.050.0300.140.160.0600.080.0400.0600W1201000.150.030.0500.020.180.120.130.050.080.060.040.040.030.03Average4800.920.050.030.240.030.030.020.010.150.120.100.030.100.060.020.050.010.021The tvar2 allele harbors an insertion of "CTCG" within exon 1 in the tva receptor gene. tvas/s=susceptible homozygote of tva receptor gene (wild genotype); tvas/r2=heterozygote of inserted CTCG; tvar2/r2=homozygote of inserted CTCG.2The tvamut502–516 is multiple allele of tvar3, tvar4, tvar5 and tvar6 in the tva receptor gene. tvas/s=susceptible homozygote of tva receptor gene (wild genotype); tvas/r3=heterozygote of deleted ACCCCGCCCC; tvas/r4=heterozygote of deleted ACCCC; tvas/r5=heterozygote of deleted CGCTCACCCC; tvas/r6=heterozygote of deleted CGCTCACCCCGCCCC; tvar3/r3=homozygote of deleted ACCCCGCCCC; tvar4/r4=homozygote of deleted ACCCC; tvar5/r5=homozygote of deleted CGCTCACCCC; tvar6/r6=homozygote of deleted CGCTCACCCCGCCCC; tvar3/r4=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r5=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r6=heterozygote of deleted ACCCCGCCCC and CGCTCACCCCGCCCC; tvar4/r5=heterozygote of deleted ACCCC and CGCTCACCCC; tvar4/r6= heterozygote of deleted ACCCC and CGCTCACCCCGCCCC; tvar5/r6= heterozygote of deleted CGCTCACCCC and CGCTCACCCCGCCCC. Genotypic frequency of resistant alleles within the tva receptor gene in Qingyuan Partridge Chicken lines. The tvar2 allele harbors an insertion of "CTCG" within exon 1 in the tva receptor gene. tvas/s=susceptible homozygote of tva receptor gene (wild genotype); tvas/r2=heterozygote of inserted CTCG; tvar2/r2=homozygote of inserted CTCG. The tvamut502–516 is multiple allele of tvar3, tvar4, tvar5 and tvar6 in the tva receptor gene. tvas/s=susceptible homozygote of tva receptor gene (wild genotype); tvas/r3=heterozygote of deleted ACCCCGCCCC; tvas/r4=heterozygote of deleted ACCCC; tvas/r5=heterozygote of deleted CGCTCACCCC; tvas/r6=heterozygote of deleted CGCTCACCCCGCCCC; tvar3/r3=homozygote of deleted ACCCCGCCCC; tvar4/r4=homozygote of deleted ACCCC; tvar5/r5=homozygote of deleted CGCTCACCCC; tvar6/r6=homozygote of deleted CGCTCACCCCGCCCC; tvar3/r4=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r5=heterozygote of deleted ACCCCGCCCC and ACCCC; tvar3/r6=heterozygote of deleted ACCCCGCCCC and CGCTCACCCCGCCCC; tvar4/r5=heterozygote of deleted ACCCC and CGCTCACCCC; tvar4/r6= heterozygote of deleted ACCCC and CGCTCACCCCGCCCC; tvar5/r6= heterozygote of deleted CGCTCACCCC and CGCTCACCCCGCCCC. Discussion Avian leukosis viruses (ALVs), particularly the classic ALV-A and emerging ALV-K, pose significant threats to the global poultry industry by inducing tumors, impairing production performance, and causing severe immunosuppression (Zhao et al., 2018; Zhang et al., 2024). Molecular epidemiological surveillance has highlighted an escalating spread of ALV-A and ALV-K in domestic chicken populations, notably in China and Southeast Asia(Li et al., 2024; Xu et al., 2025). In these conditions, populations of chickens exposed to ALV-A and ALV-K might be under positive selection pressure to develop complete or partial genetic resistance to ALV-A and ALV-K. In this study, we identified five tva alleles (tvar2, tvar3, tvar4, tvar5, and tvar6) in Qingyuan partridge chickens (QYPC), demonstrating that tvar2 confers complete resistance to ALV-A and ALV-K, while tvar3, tvar4, tvar5, and tvar6 reduce susceptibility to ALV-K, with validation in both in vitro and in vivo. The Tva protein, a cellular receptor for ALV-A and ALV-K entry, comprises an 83-amino-acid extracellular domain, a 23-amino-acid transmembrane region, and a 33-amino-acid intracellular domain (Bates et al., 1993, Přikryl et al., 2019). The extracellular domain contains a 40-amino-acid cysteine-rich low-density lipoprotein (LDL-A) module (Rai et al., 2005), stabilized by three disulfide bonds between six cysteines, which is critical for high-affinity binding to ALV-A and ALV-K envelope glycoproteins (gp85) and subsequent viral entry (Koslová et al., 2018, 2021). Key residues within the LDL-A module, including L55 and W69 for ALV-A (Chen et al., 2022), and E53, L55, H59, and G70 for ALV-K (Li et al., 2023), mediating receptor-virus interactions, emphasizing the functional importance of Tva. In the present study, we describe the tvar2 allele in the tva receptor gene causes the host complete resistance to ALV-A and ALV-K infection. One possible explanation that reconciles our findings is that the tvar2 allele contains a 4-nucleotide (CTCG) insertion in exon 1 of the tva receptor gene, which disrupts the translational reading frame of tva mRNA (Elleder et al., 2004). This frameshift is predicted to result in either a truncated TvaR2 protein or ablation of Tva expression, thereby eliminating the functional receptor required for ALV-A and ALV-K entry. In vitro infection assays using chicken embryo fibroblasts and in vivo challenge experiments confirmed that tvar2 homozygotes (tvar2/r2) were refractory to both ALV-A and ALV-K, with no detectable viral replication or clinical signs. Previous studies have characterized the tvar3, tvar4, tvar5, tvar6 alleles with similar intronic deletions comprising the branch point signal consensus sequence within the first intron of the tva receptor gene, which lead to inefficient splicing of tva mRNA and consequently decreased susceptibility to infection by ALV-A (Reinišová et al., 2012; Chen et al., 2015). In this study, we identified that the tvar3, tvar4, tvar5, tvar6 alleles leaded to significantly reduce the susceptibility of chickens to infection by ALV-K. Several plausible explanations could account for the reduced susceptibility to ALV-K arising from the tvar3, tvar4, tvar5, tvar6 alleles in the tva receptor gene. The tvas allele produce two normal tva transcripts, longer and shorter tva isoforms, which are derived from two alternatively spliced tva mRNA products (Elleder et al., 2004). Previous studies have shown that alternative splicing also occurred in the tvar3, tvar4, tvar5, tvar6 alleles, which results in the retention of the first intron and introduction of premature TGA stop codons in the longer and shorter tva mRNA forms of the tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6 homozygotes as well as the tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6 heterozygotes (Reinišová et al., 2012; Chen et al., 2015). On the other hand, a low level of non-spliced tvas mRNA were present in tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6 homozygotes and the tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6 heterozygotes, which could evidence indicate some leakage of the tva splicing process, as evidenced by their significantly reduced susceptibility to ALV-K infection. By compare with resistant heterozygotes, the normal spliced shorter tva mRNA were present in the tvas/r3, tvas/r4, tvas/r5 and tvas/r6 heterozygotes (Chen et al., 2015), which could retain a normal conformation of Tva protein and at least partially suitable for binding with ALV-K glycoproteins and sufficiently mediating the ALV-K infection. Selective breeding for enhanced genetic resistance to ALV infection has emerged as a sustainable and effective strategy for avian leukosis control (Bacon et al., 2000; Davies et al., 2009). To assess the potential for genetic improvement of resistance to ALV-A and ALV-K in Chinese chicken breeds, the identification of individuals carrying resistant genotypes at these loci is a crucial prerequisite. In the present study, we investigated the distribution of tva resistance alleles in QYPC lines. The resistant genotype tvar2/r2 was detected in QYPC lines F, K, and M. Notably, compared to the tvar2, the tvar3, tvar4, tvar5 and tvar6 alleles exhibited a broader distribution across the QYPC lines tested. Both homozygous resistant genotypes (tvar3/r3, tvar4/r4, tvar5/r5, tvar6/r6) and heterozygous resistant genotypes (tvar3/r4, tvar3/r5, tvar3/r6, tvar4/r5, tvar4/r6, tvar5/r6) were identified in the majority of the QYPC lines examined. Furthermore, the frequencies of these homozygous and heterozygous resistant tva genotypes were found to be notably high in certain QYPC lines. However, the physiological role of the Tva receptor and the potential impact of its absence in tvar allele homozygotes warrant consideration. Beyond its established function as a receptor for ALV-A and ALV-K, Tva was recently identified as a specific receptor involved in the uptake of transcobalamin-bound vitamin B12/cobalamin (Cbl) (Krchlíková et al., 2021). Additionally, Koslová et al. (2021) reported a specific cobalamin/vitamin B12 metabolic disorder in Tva knockout chickens. Notably, the absence of overt growth retardation is evident in the existing inbred chicken line 72, which carries the tvar2 allele and has been long maintained in captivity without any deleterious phenotypes. In this way, selective breeding for chickens genetically resistant to ALV-A and ALV-K has great potential in Qingyuan partridge chicken lines. In summary, this study demonstrated that the tvar2 allele confers complete resistance to both ALV-A and ALV-K infection in Chinese Qingyuan partridge chickens, as evidenced by both in vitro and in vivo assays. In contrast, the tvar3, tvar4, tvar5, tvar6 alleles conferred reduced susceptibility to ALV-K infection. Notably, previous work has shown that these four tva alleles also diminish susceptibility to ALV-A infection. Collectively, these findings provide valuable genetic targets for selective breeding programs aimed at enhancing resistance to ALV-A and ALV-K in chickens. Disclosures The authors have no relevant financial or non-financial interests to disclose. All authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.